홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Guanidine Sulfate (1:1) → 4-[2-(3-Bromophenyl)-7-(1-pyrrolidinyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine

HRID 861125
인쇄

반응식

HRID 861125 반응식
[Br:1][C:2]1[CH:3]=[C:4]([C:8]2[C:21]([C:22](=O)/[CH:23]=[CH:24]/N(C)C)=[C:11]3[CH:12]=[CH:13][CH:14]=[C:15]([N:16]4[CH2:20][CH2:19][CH2:18][CH2:17]4)[N:10]3[N:9]=2)[CH:5]=[CH:6][CH:7]=1.S(O)(O)(=O)=O.[NH2:34][C:35]([NH2:37])=[NH:36]>>[Br:1][C:2]1[CH:3]=[C:4]([C:8]2[C:21]([C:22]3[CH:23]=[CH:24][N:34]=[C:35]([NH2:37])[N:36]=3)=[C:11]3[CH:12]=[CH:13][CH:14]=[C:15]([N:16]4[CH2:20][CH2:19][CH2:18][CH2:17]4)[N:10]3[N:9]=2)[CH:5]=[CH:6][CH:7]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 499987Guanidine Sulfate (1:1)HCID 57494735(2E)-1-[2-(3-bromophenyl)-7-(1-pyrrolidinyl)pyrazolo[1,5-a]pyridin-3-yl]-3-(dimethylamino)-2-propen-1-one

생성물 1

HCID 102966504-[2-(3-Bromophenyl)-7-(1-pyrrolidinyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine수율 61%

실험 절차

In a similar manner as described in Example 1 from (2E)-1-[2-(3-bromophenyl)-7-(1-pyrrolidinyl)pyrazolo[1,5-a]pyridin-3-yl]-3-(dimethylamino)-2-propen-1-one (500 mg, 1.1 mmol) and guanidine sulfate, 4-[2-(3-bromophenyl)-7-(1-pyrrolidinyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine (300 mg, 61%) was obtained as a yellow solid. 1H NMR (d6-DMSO): δ 8.03 (d, 1H), 7.87 (d, 1H), 7.81 (s, 1H), 7.70–7.62 (m, 2H), 7.46 (t, 1H), 7.35 (t, 1H), 6.58 (broad s, 2H), 6.26 (d, 1H), 6.22 (d, 1H), 3.75 (m, 4H), 1.98 (m, 4H); MS m/z 435 (M+1); Anal. Caled. for C21H19N6Br: C, 57.94; H, 4.40; N. 19.31. Found: C, 57.91; H, 4.51; N, 19.07.

출처 및 근거

ORD 기록
ord-8c1eb196b05c4dfeb0affbe9004f91e4
출처 데이터셋
uspto-grants-2006_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07153855B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트